Combined Immunochemotherapy in Selected Patients With Metastatic Renal Cell Carcinoma: HLA Class II Genotype Can Help to Predict Response to Therapy
暂无分享,去创建一个
J. Gerss | L. Hertle | R. Kelsch | W. Sibrowski | C. Wülfing | E. Herrmann | S. Bierer | I. Hoffmeister